Tilray Brands (TLRY) Share-based Compensation (2017 - 2026)

Tilray Brands (TLRY) posted Share-based Compensation of $13.7 million for Q1 2026, up 11.74% on a QoQ basis from $12.3 million in Q4 2025, and up 240.15% year-over-year from $4.0 million in Q1 2025.

Tilray Brands (TLRY) Share-based Compensation (2017 - 2026) Analysis & Trends

Tilray Brands' Share-based Compensation history runs 10 years deep, the most recent figure standing at $13.7 million for Q1 2026.

  • Quarterly Share-based Compensation rose 240.15% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $37.2 million (up 46.06% YoY) and the FY2025 annual result came in at $24.3 million, down 23.54% from the prior year.
  • Share-based Compensation was $13.7 million for Q1 2026 at Tilray Brands, up from $12.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $16.5 million in Q4 2023 and bottomed at -$14.5 million in Q1 2022.
  • A 5-year average of $5.7 million and a median of $7.1 million in 2024 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2022 — Share-based Compensation plunged 158.87% — and 2023, when it surged 305.62%.
  • Tilray Brands' Share-based Compensation stood at -$8.0 million in 2022, then soared by 305.62% to $16.5 million in 2023, then slumped by 56.03% to $7.2 million in 2024, then soared by 69.73% to $12.3 million in 2025, then gained by 11.74% to $13.7 million in 2026.
  • Business Quant data shows TLRY's Share-based Compensation at $13.7 million in Q1 2026, $12.3 million in Q4 2025, and $5.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn 13.73 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 13.73 Mn
Feb 28, 2026 13.73 Mn
Nov 30, 2025 12.28 Mn
Nov 30, 2025 12.28 Mn
Aug 31, 2025 5.05 Mn
Aug 31, 2025 5.05 Mn
May 31, 2025 6.10 Mn
May 31, 2025 6.10 Mn
Feb 28, 2025 4.04 Mn
Feb 28, 2025 4.04 Mn
Nov 30, 2024 7.24 Mn
Nov 30, 2024 7.24 Mn
Aug 31, 2024 6.92 Mn
Aug 31, 2024 6.92 Mn
May 31, 2024 7.25 Mn
May 31, 2024 7.25 Mn
Feb 29, 2024 8.06 Mn
Feb 29, 2024 8.06 Mn
Nov 30, 2023 16.46 Mn
Nov 30, 2023 16.46 Mn